Indivior Pharmaceuticals Inc Indivior Pharmaceuticals Inc

Indivior Pharmaceuticals Inc

INDV

Pozycja w akcjach #3881
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Cena akcji
$34.01
Kapitalizacja rynkowa
$4.24B
Zmiana (1 dzień)
4.81%
Zmiana (1 rok)
38.93%
Kraj
US
Handel Indivior Pharmaceuticals Inc (INDV)

Kategoria

Healthcare
Historia stopy dywidendy dla Indivior Pharmaceuticals Inc (INDV)
Stopa dywidendy (TTM) dla Indivior Pharmaceuticals Inc (symbol akcji: INDV) na dzień 2023-12-31 wynosi: 0.00%
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Indivior Pharmaceuticals Inc (INDV) od 2016 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
2026 (TTM) 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% -100.00%
2016 2.47% 0.00%
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji